Us2.v1
Us2.ai
Produces automated measurement and preliminary reporting from echocardiographic studies, covering chamber quantification and function assessment.
At A Glance
- Manufacturer
- Us2.ai
- Medical specialty
- Cardiology
- Clearance route
- 510(k)
- Year authorized
- 2022
- Modality
- Echocardiography
- Role in workflow
- Quantification
The deployment argument for automated echo analysis is strongest where expertise is scarcest, not where it is most abundant. A tool that produces reliable chamber quantification without a cardiologist present changes what echocardiography can be used for.
Where It Is Used
- Automated echo report generation
- Screening echocardiography in resource-limited settings
- Standardized measurement in multi-site trials
Limitations Worth Knowing
Automated reports require review before they become clinical documents. Validation cohorts for echo AI are frequently drawn from tertiary centers with good image quality, which is the opposite of the setting where automation is most needed.
Regulatory status, indications, and labeling change over time. Confirm current status on the FDA's AI/ML-Enabled Medical Devices list and in the manufacturer's current instructions for use before relying on anything stated here.